Metastatic Ewing Sarcoma clinical trials

Explore recruiting metastatic ewing sarcoma clinical trials.

Recruiting metastatic ewing sarcoma studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Metastatic Ewing Sarcoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

An Open-Label, Multicenter, First-in-Human, Phase 1 Dose Escalation and Multicohort Expansion Study of INBRX-109 in Subjects with Locally Advanced or Metastatic Solid Tumors, Including Sarcomas.

France, Italy, Netherlands, Spain

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Metastatic Ewing Sarcoma trials by city

Metastatic Ewing Sarcoma clinical trials

Recruiting metastatic ewing sarcoma studies right now

A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors

Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas

Phase II Study of Irinotecan Liposome (II) Combined With Temozolomide and Fluzoparib in Recurrent or Metastatic Ewing Sarcoma

XL092 (Zanzalintinib) for the Treatment of Patients With Metastatic or Unresectable Leiomyosarcoma, Bone Sarcoma or Translocation-associated Soft Tissue Sarcoma

A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies

Indocyanine Green (ICG) Guided Tumor Resection

Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes

Targeted Oligometastatic Radiation in Pediatric and Young Adult Patients With Soft Tissue and Bone Sarcoma

Sequential Infusion of CD146-Targeted and HER2-Targeted CAR T Cells in Patients With Advanced Sarcomas

Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Also recruiting in Europe

An Open-Label, Multicenter, First-in-Human, Phase 1 Dose Escalation and Multicohort Expansion Study of INBRX-109 in Subjects with Locally Advanced or Metastatic Solid Tumors, Including Sarcomas.

Metastatic Ewing Sarcoma trials by city

Other conditions